Efficacy and Safety of Antibody-Drug Conjugates for Lung Cancer Therapy: A Systematic Review of Randomized and Non-Randomized Clinical Trials

Efficacy and Safety of Antibody-Drug Conjugates for Lung Cancer Therapy: A Systematic Review of Randomized and Non-Randomized Clinical Trials

<b>Background/Objectives</b>: Lung cancer is the leading cause of cancer-related deaths worldwide. Non-Small-Cell Lung Cancer (NSCLC) accounts for 80–90% of all lung cancers. Antibody-Drug Conjugates (ADCs) represent an expanding targeted therapy option for the treatment of NSCLC. The ai...

Full description

Saved in:
Bibliographic Details
Main Authors: Matteo Gallina, Anna Carollo, Anna Gallina, Sofia Cutaia, Sergio Rizzo, Alessio Provenzani
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Pharmaceutics
Subjects:
non-small cell lung cancer
antibody-drug conjugates
targeted therapy
tumor-agnostic therapy
systematic review
Online Access:https://www.mdpi.com/1999-4923/17/5/608
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1999-4923/17/5/608

Similar Items